Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.

@article{Dumurgier2017AlzheimersDB,
  title={Alzheimer's Disease Biomarkers and Future Decline in Cognitive Normal Older Adults.},
  author={Julien Dumurgier and Bernard J Hanseeuw and Frances B Hatling and Kelly Judge and Aaron P. Schultz and Jasmeer P. Chhatwal and Deborah Blacker and Reisa A. Sperling and Keith A. Johnson and Bradley T. Hyman and Teresa G{\'o}mez-Isla},
  journal={Journal of Alzheimer's disease : JAD},
  year={2017},
  volume={60 4},
  pages={
          1451-1459
        }
}
BACKGROUND Identifying older adults at risk of cognitive decline represents a challenge as Alzheimer's disease (AD) modifying therapies move toward preclinical stages. OBJECTIVE To investigate the relationship between AD biomarkers and subsequent change in cognition in a cohort of cognitively intact older adults. METHODS 84 cognitively normal subjects (mean age 72.0 years, 59% women) were recruited through the Massachusetts Alzheimer's Disease Research Center and the Harvard Aging Brain… CONTINUE READING

Tables and Topics from this paper.

Citations

Publications citing this paper.
SHOWING 1-8 OF 8 CITATIONS

References

Publications referenced by this paper.
SHOWING 1-10 OF 41 REFERENCES

Neuronal injury biomarkers and prognosis in ADNI subjects with normal cognition

  • Acta neuropathologica communications
  • 2014
VIEW 4 EXCERPTS
HIGHLY INFLUENTIAL